Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma

por Dasgeb, Bahar, Mohammadi, Tarana M, Mehregan, Darius R
Publicado 2013

Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions

por Dass, Sabrina E, Huizenga, Taryn, Farshchian, Mehdi, Mehregan, Darius R
Publicado 2021

Next-generation sequencing in dermatology

por King, Andrew D., Deirawan, Hany, Klein, Paytra A., Dasgeb, Bahar, Dumur, Catherine I., Mehregan, Darius R.
Publicado 2023

Rad6 is a Potential Early Marker of Melanoma Development

por Rosner, Karli, Adsule, Shreelekha, Haynes, Brittany, Kirou, Evangelia, Kato, Ikuko, Mehregan, Darius R., Shekhar, Malathy P.V.
Publicado 2014

Melanoma Development and Progression Are Associated with Rad6 Upregulation and β-Catenin Relocation to the Cell Membrane

por Rosner, Karli, Mehregan, Darius R., Kirou, Evangelia, Abrams, Judith, Kim, Seongho, Campbell, Michelle, Frieder, Jillian, Lawrence, Kelsey, Haynes, Brittany, Shekhar, Malathy P. V.
Publicado 2014

Multicenter, prospective feasibility study of Nano-Pulse Stimulation™ technology for the treatment of both nodular and superficial low-risk basal cell carcinoma

por Ross, Amy S., Schlesinger, Todd, Harmon, Christopher B., Moy, Ronald L., Rohrer, Thomas E., Mehregan, Darius R., Nuccitelli, Richard, Johnston, Lauren Jauregui, Knape, William A.
Publicado 2022